Mind Medicine (MindMed) Inc MNMD

Buzz on the Bullboards: TSX spotlight – Bombardier, Sonoro, PyroGenesis

[Jonathon Brown]

Bombardier’s aviation advancements, Sonoro’s acquisition, and PyroGenesis' biofuel contributions highlight the opportunities in the Canada. read article.

[Robert1999]

49.12% % of Shares Held by Institutions 50.47% % of Float Held by Institutions 161 Number of Institutions Holding Shares % was 5%, 1 month ago...very promising

[Starkicker]

This doesn't look great. PTSD treatment was kind of MM's thing. https://www.forbes.com/sites/roberthart/2024/06/05/psychedelic-stocks-tank-after-fda-advisors-shoot-down-mdma-therapy-for-ptsd/

[sollmg]

Further searching found this on seeking alpha https://seekingalpha.com/news/4113189-rbc-recommends-buying-mindmed-amid-psychedelic-stocks-sell-off RBC recommends buying MindMed amid psychedelic

[Robert1999]

100% agree It's not the time to sell

[sollmg]

I looked for news to try and find a reason for the price movement. Found nothing bad. Then looked at the shorts. 22% of the float short. looks like a bear attack. Also looked at the institutional

[PressRelease]

-A single oral administration of MM120 100 µg met its primary and key secondary endpoints and maintained clinically and statistically significant HAM-A reductions compared to placebo at 12 weeks with a 65% clinical response rate and a 48% clinical remission rate--MindMed also presents two new...read article.

[PressRelease]

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it plans to host a conference call on Wednesday, May 8, 2024, at 4:30 p.m. ET to provide a...read article.

[PressRelease]

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it will present detailed results from its phase 2b study of MM120 in Generalized Anxiety...read article.

[Starkicker]

You might have to call your broker to request a transfer to NSDQ otjerwise the shares will show up in your account but the values won't and you won't be able to trade them. Only takes one to

[Starkicker]

They'll just get transferred. You'll still own the same amount. Your account will probably show in USD though.

[dave1100]

What will happen to my Canadian shares once MMED is only on the nasdaq?

[Bigmoneytalks]

Hell of a day! Big volume as well 

[PressRelease]

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (Cboe Canada: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it will present posters describing the impact that COVID has had on...read article.

[PressRelease]

All Common shares will remain listed on Nasdaq Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (Cboe Canada: MMED) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it has elected to...read article.

[Bigmoneytalks]

Not a lot of chatter on the forum... It has been a nice jump in SP the last 3 weeks and holding at current prices. What are some predictions on SP the next 3 months?